Viewing Study NCT05266469


Ignite Creation Date: 2025-12-24 @ 11:04 PM
Ignite Modification Date: 2026-01-02 @ 12:26 AM
Study NCT ID: NCT05266469
Status: COMPLETED
Last Update Posted: 2025-07-09
First Post: 2022-02-23
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Exploring the Profiles of RMS Patients on Ofatumumab or Ocrelizumab in a Real-World Setting in the Gulf
Sponsor: Novartis Pharmaceuticals
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module